Gene Query: STXBP3

Dataset Description Geneva Score
Transcriptome analysis of kidney organoids 36.93
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 25.9
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 20.87
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 18.84
Expression by CD133+ cells isolated from the adult human exocrine pancreas 16.98
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 15.17
TCF7L1 knockdown in pancreatic cancer 14.89
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 14.31
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 14.31
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 13.96
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 13.86
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 13.32
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 13.32
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 13.0
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 12.4
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 11.62
RNAseq Analysis in glioblastoma cells treated with Mepazine 11.6
Human cell line and subcutaneous tumor 11.13
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 10.96
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 10.8
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 10.66
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 10.52
RNA-seq of Single-Cell Genotyping of Transcriptomes 10.48
Single-Cell Genotyping of Transcriptomes 10.48
Effect of PRDM11 depletion in U2932 cells 10.19
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 10.19
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 10.12
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 10.09
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 10.07
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 9.83
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 9.64
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 9.6
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 9.1
RNA sequencing of BT142 and TS603 cell lines 8.83
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 8.83
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 8.82
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 8.75
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 8.66
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 8.58
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 8.56
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 8.23
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 8.23
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 8.19
mRNA expression profile of Lymphocytes 8.09
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 7.97
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 7.97
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 7.74
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 7.73
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 7.73
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 7.68
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 7.65
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 7.57
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 7.57
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 7.56
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 7.39
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 7.36
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 7.08
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 7.08
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 7.07
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 6.93
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 6.86
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 6.85
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 6.79
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 6.74
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 6.72
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 6.72
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 6.68
Gene expression profiling of leukemia cells following asparagine depletion 6.6
Effect of CHKA knockdown on C4-2 cell transcriptome 6.57
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 6.52
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 6.52
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 6.47
RNAseq of cell lines with knocked in ESR1 mutations 6.35
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 6.3
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 6.3
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 6.29
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 6.27
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 6.27
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 6.27
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 6.21
MAIT cell RNA sequencing 6.2
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 6.15
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 6.11
Uridylation by TUT4 and TUT7 marks mRNA for degradation 6.07
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 6.07
LncRNA expression profiling of ischemic stroke patients 6.04
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 6.01
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 5.99
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 5.93
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 5.92
MOF acetyl transferase regulates transcription and respiration in mitochondria 5.91
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 5.87
RNA-Seq from human ILC transitional populations 5.87
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 5.81
Analysis of transcriptional regulation by Myt1 and Myt1l 5.81
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 5.72
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 5.59
K562 polyA RNA-Seq 5.56
Integrating single-cell transcriptomic data across different conditions, technologies, and species 5.54
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 5.5
Effect of mitochondria deficiency on senescence-associated gene expression 5.42
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 5.41
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 5.41
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 5.39
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 5.39
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 5.39
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 5.37
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 5.35
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 5.34
The transcriptome effect of overexpressing EZH2 in MCF7 5.32
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 5.32
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 5.32
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 5.3
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 5.29
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 5.27
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 5.25
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 5.2
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 5.2
Interaction between mitoNEET and NAF-1 in cancer cells 5.15
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 5.1
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 5.1
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 5.08
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 5.08
Tracking distinct RNA populations using efficient and reversible covalent chemistry 5.05
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 5.05
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 5.03
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 5.02
High-throughput sequencing of PROMPT-enriched samples. 4.99
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 4.98
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 4.92
CROP-Seq in Primary Human T Cells 4.91
Effect of PBK knockdown on C4-2 cell transcriptome 4.88
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 4.83
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 4.83
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 4.82
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 4.78
Patient-derived luminal breast cancer xenografts with progestins 4.75
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 4.75
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 4.74
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 4.73
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 4.73
TGF-β regulation of miRNA expression in pancreatic cancer 4.68
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 4.68
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 4.64
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 4.63
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 4.63
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 4.62
RNA-seq analysis of differentiating human erythroblasts 4.62
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 4.58
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 4.58
Developmental stage specific chromosome architecture in human erythroid cells 4.58
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 4.57
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 4.57
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 4.57
Comparing gene expression in iPSC derived RPE from control and AMD donors 4.56
R430: A potent inbibitor of DNA and RNA viruses 4.55
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 4.55
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 4.53
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 4.53
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 4.51
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 4.48
Single-cell analysis of human kidney organoids 4.48
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 4.4
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 4.34
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 4.34
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 4.3
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 4.3
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 4.3
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 4.3
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 4.28
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 4.28
Gene expression alterations of pancreatic intraepithlial neoplasia 4.25
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 4.25
Induced DNA demethylation, genome instability and transcription 4.25
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 4.22
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 4.22
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 4.19
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 4.17
Differential gene expression of human melanoma cells [RNA-seq] 4.17
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 4.15
Total RNA-seq in ALL-SIL upon TLX1 knockdown 4.14
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 4.13
Biological effect of chronic mistranslation in mammalian cells 4.12
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 4.11
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 4.11
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 4.11
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 4.06
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 4.03
Global Mapping of Human RNA-RNA Interactions 3.99
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 3.97
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 3.97
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 3.95
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 3.95
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 3.94
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 3.93
A map of gene expression in neutrophil-like cell lines 3.93
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 3.92
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 3.92
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 3.88
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 3.87
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 3.85
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 3.83
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 3.83
TOP2B disturbed the quality of human oocytes with advanced maternal age 3.82
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 3.82
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 3.82
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 3.82
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.76
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 3.73
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 3.73
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 3.7
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 3.68
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 3.67
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 3.66
MYCL and EP400 are required for Max and MCPyV mediated gene activation 3.65
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 3.64
RNAseq Study in CC-671 Treated Cal-51 Cells 3.64
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 3.63
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 3.6
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 3.58
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 3.58
Regulation of protein translation during mitosis 3.53
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 3.51
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 3.51
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 3.48
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 3.48
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 3.47
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 3.46
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 3.46
Transcriptome analysis of peripheral blood monocytes 3.46
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 3.45
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 3.45
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 3.44
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 3.44
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 3.44
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 3.44
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 3.43
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 3.43
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 3.39
Universal alternative splicing of noncoding exons 3.38
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 3.36
Hepatitis C virus functionally sequesters miR-122 3.34
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 3.34
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 3.32
The age and genomic integrity of neurons after cortical stroke in humans 3.31
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 3.3
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 3.29
Transcriptional profile in human S. haematobium infection 3.28
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 3.25
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 3.23
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 3.21
Transcriptomic analysis of LSD1 3.19
Transcriptional landscape changes during human embryonic stem cell derivation 3.15
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 3.15
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 3.15
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 3.13
Hypoxic transcriptome of SQ20B human head and neck cancer cells 3.13
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 3.11
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 3.09
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 3.09
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 3.08
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 3.07
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 3.07
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 2.99
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 2.99
LIN28A Over-expression RNAseq 2.98
Microglia innatly develop within cerebral organoids 2.94
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 2.92
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 2.91
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 2.9
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 2.89
Mapping interactions for the TNIP2 hub protein 2.87
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 2.87
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 2.84
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 2.82
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 2.82
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 2.82
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 2.81
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 2.79
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 2.79
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 2.79
Active translatome profiling with RiboLace in MCF7 cells 2.72
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 2.72
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 2.69
UBC9 knockdown in bladder cancer T24 cell lines 2.67
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 2.65
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 2.64
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 2.61
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 2.61
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 2.6
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 2.52
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 2.52
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.52
Identification of renal resident macrophages across species [C1] 2.51
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 2.49
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 2.47
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 2.46
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 2.45
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 2.42
Activity-dependent transcriptional changes in human neurons 2.41
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 2.38
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 2.37
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 2.36
Measure transcript integrity using RNA-seq data 2.35
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.29
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 2.27
Effect of from Human Umbilical Vein Endothelial Cells 2.24
Trascriptome of thyroid cancer-induced macrophages 2.24
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 2.23
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 2.23
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 2.23
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 2.21
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 2.17
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 2.16
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 2.13
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 2.13
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 2.12
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 2.12
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 2.1
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 2.06
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 2.05
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 2.05
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 2.03
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 2.03
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 2.01
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.98
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 1.97
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 1.97
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 1.95
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 1.93
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 1.93
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.91
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.85
RNA sequencing of human mammary epithelial cells 1.77
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 1.75
The contribution of Alu exons to the human proteome 1.74
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 1.71
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 1.71
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.71
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.66
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 1.65
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 1.65
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 1.65
Identification of renal resident macrophages across species 1.64
RNA-Seq of PRMT1 overexpression ECA109 cells 1.64
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 1.63
p53 activity results in DNA replication fork processivity 1.63
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.63
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 1.61
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 1.59
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 1.58
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 1.58
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.56
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.56
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.56
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 1.56
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 1.55
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 1.55
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 1.55
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 1.55
mRNA recovered upon RNF219 IP. [RNA-IP] 1.53
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 1.52
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 1.5
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.49
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 1.49
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 1.49
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 1.49
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.49
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 1.48
RNA-seq analysis of control and Myc-induced U2OS cells 1.48
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.46
Defective structural RNA processing in relapsing-remitting multiple sclerosis 1.46
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 1.45
Dermal endothelial cells of type 2 diabetic patients 1.4
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 1.4
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 1.39
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 1.37
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 1.35
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 1.34
An optimization system for isolating and sequencing of single human colon cancer cells 1.33
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 1.31
Electronic cigarettes 1.3
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.29
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 1.27
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 1.26
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 1.25
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 1.25
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.24
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.24
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 1.21
Human Treg IL-12 stimulation 1.2
RNA sequencing of primary human platelets and in vitro cell lines 1.19
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 1.17
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 1.16
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 1.11
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.08
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.08
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 1.08
A single cell reference map for human blood and tissue T cell activation 1.07
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.04
Transcriptional profiling of LS1034 cells treated with tepoxalin 1.03
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 1.02
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 1.02
Transcriptome-wide response to synthetic chromatin protein PcTF 1.02
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.01
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 1.01
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 1.0
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 1.0
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 1.0
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.99
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.99
Transcriptome profiling of 5 human adenocarcinoma cell lines 0.99
Positively selected enhancer elements endow tumor cells with metastatic competence 0.99
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 0.98
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 0.96
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.96
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.95
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 0.94
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 0.94
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.93
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 0.92
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.92
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.92
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.91
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 0.9
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 0.87
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.84
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.83
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.8
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.78
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.76
RNA-seq data 0.75
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.73
DAOY-Notch1/Notch2 knockout: transcriptome comparison 0.72
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.72
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.69
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.68
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.68
Aging-associated patterns in the expression of human endogenous retroviruses 0.68
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.67
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.66
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.66
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.64
PTHrP overexpression in MCF7 cells 0.64
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 0.63
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 0.59
RNA-seq of primary patient AML samples 0.58
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.58
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.56
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.56
Transcriptome-wide modulation of splicing by the exon junction complex 0.56
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.53
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.51
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.5
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.48
6mer seed toxicity in tumour suppressive microRNAs 0.46
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 0.46
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 0.44
RNA seq comparison between scrambled and shGRP78 cells 0.44
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.43
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 0.43
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.42
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.42
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.41
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 0.41
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.4
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 0.39
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 0.38
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.38
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 0.36
RNA-Seq in neutrophils from Antiphospholipid Syndrome 0.35
siRNA-mediated knockdown 0.34
FOXP1 orchestration of ASD-relevant signaling pathways. 0.34
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 0.32
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 0.32
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.3
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 0.28
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 0.27
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.26
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.24
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 0.21
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.21
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.2
Genome-wide analysis of the Integrator complex (HTS) 0.16
Genome-wide analysis of the Integrator complex 0.16
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.15
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.12
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.11
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.11
Modulation of nonsense-mediated decay by rapamycin 0.07
HNRNPM-regulated splicing dependencies in prostate cancer 0.05
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.05
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.05
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.04
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.04
Human Treg IFNg/IL-10 subpopulations 0.03
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 0.02
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.02
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.01
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation